Predicting lymph node invasion in patients treated with robot-assisted radical prostatectomy.

Firas Abdollah(Henry Ford Health System), Mani Menon(Henry Ford Hospital), Dane Klett(Henry Ford Health System), Deepansh Dalela(Henry Ford Health System), James O. Peabody(Henry Ford Hospital), Linda Hsu(Henry Ford Health System), Nilesh Gupta(Henry Ford Health System), Jesse D. Sammon(Henry Ford Hospital), Quoc Dien Trinh(Harvard University Press), Mireya Díaz(American Urological Association)
PubMed
February 1, 2016
Cited by 2

Related Papers

Evaluation and Treatment of Cryptorchidism: AUA Guideline
|The Journal of Urology|2014|508
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
|Clinical Cancer Research|2013|358
Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma
|Modern Pathology|2014|227
ERG gene rearrangements are common in prostatic small cell carcinomas
|Modern Pathology|2011|219
Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM
|PLoS ONE|2012|215